PharmAust CEO's sayanora triggers stock plunge
Clinical-stage biotechnology company, PharmAust shares plunged 24 per cent so this morning, following the resignation of its CEO, Dr. Michael Thurn.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Last update - 15.08pm 24/04/2024 (20 minute delay)
?
Day | ||||||||
---|---|---|---|---|---|---|---|---|
Open | 6.0¢ | Day High | 6.0¢ | Day Low | 5.8¢ | |||
Daily Volume | 226557 |
Bids | Sellers | |||||
---|---|---|---|---|---|---|
Number | Price | Volume | Number | Price | Volume | |
2 | 5.7¢ | 101142 | 2 | 6.0¢ | 110495 |
Directors & Senior Management
Mr. Brian Bernard Rodan | Non-Executive Chairman of the Board |
Mr. Victor Rajasooriar | Chief Executive Officer, Managing Director, Director |
Mr. Paul Angus | Technical Director, Non-Executive Director |
Mr. Sebastian Andre | Company Secretary |
Mr. Keith Charles Murray | Non-Executive Independent Director |
Data source: Refinitiv